Genelux (GNLX) Return on Capital Employed Growth (1y) (2024 - 2025)

Genelux (GNLX) Return on Capital Employed Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Nanobiotix 1,769.80 Bn 1,769.74 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 31,429.00
3 BeOne Medicines 473.64 Bn 468.85 Bn 1.35 Bn 1,805.00
4 Vertex Pharmaceuticals 123.74 Bn 116.49 Bn 2.59 Bn 2,503.00
5 Regeneron Pharmaceuticals 71.73 Bn 62.97 Bn 3.31 Bn -105.00
6 Belite Bio 62.10 Bn 62.10 Bn - -
7 Argenx Se 54.68 Bn 49.49 Bn 1.41 Bn -
8 Alnylam Pharmaceuticals 38.13 Bn 35.12 Bn 959.66 Mn 2,400.00
9 Revolution Medicines 36.21 Bn 36.21 Bn - -3,457.00
10 Genelux 128.04 Mn 128.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -10,684.00
Sep 30, 2025 -6,494.00
Dec 31, 2024 -469.00